Skip to main content
. 2016 Nov 4;48(11):e269. doi: 10.1038/emm.2016.119

Figure 1.

Figure 1

REDOX adaptation in cancer. Low levels of ROS can activate various signaling pathways to stimulate cell proliferation and survival. Adaptation to persistent and high levels of ROS can promote cancer development, survival of cancer cells and resistance to chemotherapeutics.